{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:01:52Z","timestamp":1761663712372},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,2,20]]},"DOI":"10.18632\/oncotarget.24391","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T11:55:11Z","timestamp":1517658911000},"page":"11631-11637","source":"Crossref","is-referenced-by-count":11,"title":["Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis"],"prefix":"10.18632","volume":"9","author":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan"},{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadahisa","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Kiyono","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Ooka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Imazeki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Dusheiko","year":"2014","journal-title":"J Hepatol"},{"key":"2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12072-010-9193-3","article-title":"New antiviral therapies for chronic hepatitis C","volume":"4","author":"Yokosuka","year":"2010","journal-title":"Hepatol Int"},{"key":"3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12072-016-9749-y","article-title":"Interferon-free treatment for HCV-infected patients with decompensated cirrhosis","volume":"11","author":"Kanda","year":"2017","journal-title":"Hepatol Int"},{"key":"4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","article-title":"Autoimmune hepatitis in Japan: trends in a nationwide survey","volume":"52","author":"Yonemoto","year":"2017","journal-title":"J Gastroenterol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: From \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Poupon","year":"2015","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12328-016-0648-5","article-title":"Autoimmune hepatitis following drug-induced liver injury in an elderly patient","volume":"9","author":"Yokosuka","year":"2016","journal-title":"Clin J Gastroenterol"},{"key":"7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-002-1102-7","article-title":"Bezafibrate treatment: a new medical approach for PBC patients?","volume":"38","author":"Saisho","year":"2003","journal-title":"J Gastroenterol"},{"key":"8","first-page":"127","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","volume":"13","author":"Dalekos","year":"2013","journal-title":"Ann Hepatol"},{"key":"9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4254\/wjh.v5.i10.577","article-title":"Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome","volume":"5","author":"Dalekos","year":"2013","journal-title":"World J Hepatol"},{"key":"10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(96)90212-3","article-title":"Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus","volume":"347","author":"Concia","year":"1996","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"e75613","DOI":"10.1371\/journal.pone.0075613","article-title":"Variation of transaminases, HCV-RNA levels and Th1\/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C","volume":"8","author":"Sanju\u00e1n-N\u00fa\u00f1ez","year":"2013","journal-title":"PLoS One"},{"key":"12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"Rosen","year":"2015","journal-title":"J Viral Hepat"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Werner, Adenugba, Protzer. Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC? Transplantation. 2017; 101:904\u2013909.","DOI":"10.1097\/TP.0000000000001606"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12836","article-title":"IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR","volume":"29","author":"Chung","year":"2017","journal-title":"J Viral Hepat"},{"key":"15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12072-012-9342-y","article-title":"APASL consensus statements and management algorithms for hepatitis C virus infection","volume":"6","author":"Sarin","year":"2012","journal-title":"Hepatol Int"},{"key":"16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2169\/internalmedicine.56.7948","article-title":"Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection","volume":"56","author":"Moriyama","year":"2017","journal-title":"Intern Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","article-title":"Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C","volume":"26","author":"Manns","year":"1997","journal-title":"J Hepatol"},{"key":"18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/14740338.2017.1325869","article-title":"Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals","volume":"16","author":"Chung","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29528","article-title":"Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient","volume":"16","author":"Moradpour","year":"2017","journal-title":"Hepatology"},{"key":"20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0016-5085(92)90786-X","article-title":"Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C","volume":"102","author":"Hoofnagle","year":"1992","journal-title":"Gastroenterology"},{"key":"21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/BF02065528","article-title":"Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C","volume":"40","author":"Yamamoto","year":"1995","journal-title":"Dig Dis Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/BF02208992","article-title":"Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection","volume":"40","author":"Consoli","year":"1995","journal-title":"Dig Dis Sci"},{"key":"23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7150\/ijms.15519","article-title":"Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan","volume":"13","author":"Yokosuka","year":"2016","journal-title":"Int J Med Sci"},{"key":"24","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.3390\/ijms18050906","article-title":"Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3\/4A Inhibitors","volume":"18","author":"Wu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"25","first-page":"E30","article-title":"Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin","volume":"6","author":"Imazeki","year":"2017","journal-title":"Biology (Basel)"},{"key":"26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Fainboim","year":"1999","journal-title":"J Hepatol"},{"key":"27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Schramm","year":"2008","journal-title":"Hepatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:01:56Z","timestamp":1589025716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,2,20]]}},"alternative-id":["24391","29545925"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24391","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}